Hepcidin in trauma: Linking injury, inflammation, and anemia

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 4, 2010, Pages 831-836

  Sihler, Kristen C ^a   Raghavendran, Krishnan ^a   Westerman, Mark ^b   Ye, Wen ^c   Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Intrinsic Life Sciences   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anemia; Hemoglobin; Hepcidin; Inflammation; Trauma

Indexed keywords

CXCL1 CHEMOKINE; GAMMA INTERFERON; HEMOGLOBIN; HEPCIDIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; IRON; LACTIC ACID; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN; NERVE GROWTH FACTOR BETA SUBUNIT; TRANSFERRIN; TRANSFERRIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANEMIA; ARTICLE; DISEASE DURATION; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HYPOXIA; INFLAMMATION; INJURY SCALE; INJURY SEVERITY; INTENSIVE CARE; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; TIME; URINALYSIS;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; ANOXIA; ANTIMICROBIAL CATIONIC PEPTIDES; COHORT STUDIES; CYTOKINES; ERYTHROPOIESIS; FEMALE; HEMOGLOBINOMETRY; HOMEOSTASIS; HOSPITAL MORTALITY; HUMANS; INFLAMMATION MEDIATORS; INJURY SEVERITY SCORE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE TRAUMA; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SURVIVAL RATE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WOUNDS, NONPENETRATING;

EID: 77958176980     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181f066d5     Document Type: Article

References (32)

1. Napolitano LM. Scope of the problem: epidemiology of anemia and useof blood transfusions in critical care. Crit Care. 2004;8(suppl 2): S1-SS.
2. Shapiro MJ, Gettinger A, Corwin HL, et al. Anemia and blood transfusionin trauma patients admitted to the intensive care unit. J Trauma.2003;55: 269-273; discussion 273-274.
3. Sihler KC, Napolitano LM. Anemia of inflammation in critically illpatients. J Intensive Care Med. 2008;23: 295-302.
4. Ganz T. Iron homeostasis: fitting the puzzle pieces together. Cell Metab.2008;7: 288-290.
5. Park CH, Valore EV, Waring AJ, Ganz T. Hepcidin, a urinary antimicrobialpeptide synthesized in the liver. J Biol Chem. 2001;276: 7806-7810.
6. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin regulates cellular ironefflux by binding to ferroportin and inducing its internalization. Science.2004;306: 2090-2093.
7. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia ofinflammation by inducing the synthesis of the iron regulatory hormonehepcidin. J Clin Invest. 2004;113: 1271-1276.
8. Ganz T. Hepcidin\-a regulator of intestinal iron absorption and ironrecycling by macrophages. Best Pract Res Clin Haematol. 2005;18: 171-182.
9. Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol.2008;15: 169-175.
10. De Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing outthe details. J Clin Invest. 2007;117: 1755-1758.
11. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulationof bone morphogenetic protein signaling in vivo regulates systemiciron balance. J Clin Invest. 2007;117: 1933-1939.
12. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in ironoverload disorders. Blood. 2005;105: 4103-4105.
13. Kemna E, Pickkers P, Nemeth E, van der Hoeven H, Swinkels D.Time-course analysis of hepcidin, serum iron, and plasma cytokinelevels in humans injected with LPS. Blood. 2005;106: 1864-1866.
14. Bansal SS, Halket JM, Bomford A, et al. Quantitation of hepcidin inhuman urine by liquid chromatography-mass spectrometry. Anal Biochem.2009;384: 245-253.
15. Sharma S, Nemeth E, Chen YH, et al. Involvement of hepcidin in theanemia of multiple myeloma. Clin Cancer Res. 2008;14: 3262-3267.
16. Rodriguez RM, Corwin HL, Gettinger A, Corwin MJ, Gubler D, PearlRG. Nutritional deficiencies and blunted erythropoietin response ascauses of the anemia of critical illness. J Crit Care. 2001;16: 36-41.
17. Rogiers P, Zhang H, Leeman M, et al. Erythropoietin response is bluntedin critically ill patients. Intensive Care Med. 1997;23: 159-162.
18. Biffl WL, Moore EE, Offner PJ, Ciesla DJ, Gonzalez RJ, Silliman CC.Plasma from aged stored red blood cells delays neutrophil apoptosis andprimes for cytotoxicity: abrogation by poststorage washing but notprestorage leukoreduction. J Trauma. 2001;50: 426-431; discussion432.
19. Escobar GA, Cheng AM, Moore EE, et al. Stored packed red blood celltransfusion up-regulates inflammatory gene expression in circulatingleukocytes. Ann Surg. 2007;246: 129-134.
20. Zallen G, Moore EE, Ciesla DJ, Brown M, Biffl WL, Silliman CC.Stored red blood cells selectively activate human neutrophils to releaseIL-8 and secretory PLA2. Shock. 2000;13: 29-33.
21. Hobisch-Hagen P, Wiedermann F, Mayr A, et al. Blunted erythropoieticresponse to anemia in multiply traumatized patients. Crit Care Med.2001;29: 743-747.
22. Ganz T. Molecular control of iron transport. J Am Soc Nephrol. 2007;18: 394-400.
23. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS,Lafuse WP. Expression and localization of hepcidin in macrophages: arole in host defense against tuberculosis. J Leukoc Biol. 2007;82: 934-945.
24. Freund-Michel V, Frossard N. The nerve growth factor and its receptorsin airway inflammatory diseases. Pharmacol Ther. 2008;117: 52-76.
25. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation.Front Biosci. 1997;2: d12-d26.
26. Schümann K, Kroll S, Weiss G, et al. Monitoring of hematological,inflammatory and oxidative reactions to acute oral iron exposure inhuman volunteers: preliminary screening for selection of potentiallyresponsivebiomarkers. Toxicology. 2005;212: 10-23.
27. Roy CN, Andrews NC. Anemia of inflammation: the hepcidin link. CurrOpin Hematol. 2005;12: 107-111.
28. Roy CN, Mak HH, Akpan I, Losyev G, Zurakowski D, Andrews NC.Hepcidin antimicrobial peptide transgenic mice exhibit features of theanemia of inflammation. Blood. 2007;109: 4038-4044.
29. Dallalio G, Law E, Means RT Jr. Hepcidin inhibits in vitro erythroidcolony formation at reduced erythropoietin concentrations. Blood. 2006;107: 2702-2704.
30. Nicolas G, Viatte L, Bennoun M, Beaumont C, Kahn A, Vaulont S.Hepcidin, a new iron regulatory peptide. Blood Cells Mol Dis. 2002;29: 327-335.
31. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression ofhepcidin during anemia requires erythropoietic activity. Blood. 2006;108: 3730-3735.
32. Ashby DR, Gale DP, Busbridge M, et al. Plasma hepcidin levels areelevated but responsive to erythropoietin therapy in renal disease.Kidney Int. 2009;75: 976-981.